• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPROT
Stromacel Inc
10.0
0.0x
---
United StatesMTST
MetaStat Inc
590.0
0.0x
---
United StatesBSYI
BioSyntech Inc
1.2K
0.0x
---
United StatesBIOAF
Bioasis Technologies Inc
7.9K
0.0x
---
United StatesNNBP
Nanobac Pharmaceuticals Inc
250.0
0.0x
---
United StatesHMPQ
HempAmericana Inc
2.9K
---
---
As of 2024-11-22

Company Information

Stromacel Inc. is a biotechnology company. The Company is a subsidiary of Proteonomix Inc. It offers technology in the field of cellular medicine to international clients. The Company intends to conduct phased human studies of its cellular materials in application to the treatment of cardiac and other diseases.

Contact Information

Headquarters
187 Mill LnMOUNTAINSIDE, NJ, United States 07092-2918
Phone
973-544-6116
Fax
302-531-3150

Executives

Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer
Michael Cohen
Chief Financial Officer
Thomas Monahan
Chief Technical Officer, Director
Steven Byle
Vice President - Scientific Development , Chief Scientific Officer, Director
Ian Mcniece
General Counsel, Treasurer, Director
Roger Fidler

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.00
Revenue (TTM)
$26.0K
Shares Outstanding
7.9M
Stromacel Inc does not pay a dividend.
Beta
---
EPS
$-0.10
Book Value
$-0.48
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-14,546.69%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.